New camera eye could catch colon cancer early in IBD patients
NCT ID NCT07271264
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new imaging technique called Texture and Colour Enhancement Imaging (TXI) with standard white light during colonoscopy in 219 people with inflammatory bowel disease (IBD). The goal is to see if TXI finds more dysplastic (precancerous) lesions. Each patient will have both methods used in different parts of their colon, and the number of lesions detected will be compared.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Texture and Colour Enhancement Imaging (TXI) system
What this could lead to
If TXI proves better at detecting dysplasia, it could become a new standard for IBD surveillance, catching precancerous changes earlier.
What could go wrong
This is a relatively small, early-stage study. TXI may not outperform standard white light, and results may not apply to all IBD patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Central Middlesex Hospital
RECRUITINGLondon, NW10 7NS, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••